^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    bleximenib (JNJ-6617)

    i
    Other names: JNJ-6617, JNJ 75276617, JNJ75276617, JNJ-75276617, JNJ6617, JNJ 6617
    Company:
    J&J
    Drug class:
    MLL1 inhibitor